TY - JOUR
T1 - Vaccine preferences and acceptance of older adults
AU - Eilers, Renske
AU - de Melker, H E
AU - Veldwijk, J
AU - Krabbe, P F M
N1 - Copyright © 2017 Elsevier Ltd. All rights reserved.
PY - 2017/5/15
Y1 - 2017/5/15
N2 - BACKGROUND: Expanding vaccination programs for the older population might be important as older adults are becoming a larger proportion of the general population. The aim of this study is to determine the relative importance of vaccine and disease specific characteristics and acceptance for Dutch older adults, including pneumococcal disease, herpes zoster, pertussis vaccination, and influenza vaccination.METHODS: A discrete choice experiment was conducted to generate choice data that was analyzed using a mixed multinomial logit statistical model.RESULTS: Important factors that were associated with vaccination acceptance in older adults are high mortality risk of the infectious disease, high susceptibility of getting the infectious disease, and high vaccine effectiveness. Age, influenza vaccination in 2013 and self-perceived health score were identified as personal factors that affect vaccine preference. Potential vaccination rates of older adults were estimated at 68.1% for pneumococcal vaccination, 58.1% for herpes zoster vaccination, 53.9% for pertussis vaccination and 54.3% for influenza vaccination. For persons aged 50-65, potential vaccination rates were estimated at 58.1% for pneumococcal vaccination, 49.5% for herpes zoster vaccination, 43.9% for pertussis vaccination and 42.2% for influenza vaccination. For persons aged 65 and older, these were respectively 76.2%, 67.5%, 57.5% and 65.5%.DISCUSSION: Our results suggest that older adults are most likely to accept pneumococcal vaccination of the four vaccines. Information provision accompanied with the implementation of a new vaccine has to be tailored for the individual and the vaccine it concerns. Special attention is needed to ensure high uptake among persons aged 50-65years.
AB - BACKGROUND: Expanding vaccination programs for the older population might be important as older adults are becoming a larger proportion of the general population. The aim of this study is to determine the relative importance of vaccine and disease specific characteristics and acceptance for Dutch older adults, including pneumococcal disease, herpes zoster, pertussis vaccination, and influenza vaccination.METHODS: A discrete choice experiment was conducted to generate choice data that was analyzed using a mixed multinomial logit statistical model.RESULTS: Important factors that were associated with vaccination acceptance in older adults are high mortality risk of the infectious disease, high susceptibility of getting the infectious disease, and high vaccine effectiveness. Age, influenza vaccination in 2013 and self-perceived health score were identified as personal factors that affect vaccine preference. Potential vaccination rates of older adults were estimated at 68.1% for pneumococcal vaccination, 58.1% for herpes zoster vaccination, 53.9% for pertussis vaccination and 54.3% for influenza vaccination. For persons aged 50-65, potential vaccination rates were estimated at 58.1% for pneumococcal vaccination, 49.5% for herpes zoster vaccination, 43.9% for pertussis vaccination and 42.2% for influenza vaccination. For persons aged 65 and older, these were respectively 76.2%, 67.5%, 57.5% and 65.5%.DISCUSSION: Our results suggest that older adults are most likely to accept pneumococcal vaccination of the four vaccines. Information provision accompanied with the implementation of a new vaccine has to be tailored for the individual and the vaccine it concerns. Special attention is needed to ensure high uptake among persons aged 50-65years.
KW - aged
KW - 80 and over
KW - communicable diseases/epidemiology
KW - female
KW - humans
KW - male
KW - middle aged
KW - models, Statistical
KW - Netherlands/epidemiology
KW - patient acceptance of health care
KW - vaccination/statistics & numerical data
KW - vaccines/administration & dosage
KW - 80 en ouder
KW - oud
KW - overdraagbare ziekten/epidemiologie
KW - vrouwelijk
KW - mensen
KW - mannelijk
KW - middelbare leeftijd
KW - modellen, statistisch
KW - Nederland/epidemiologie
KW - patiënt acceptatie van gezondheidszorg
KW - vaccinatie/statistieken en numerieke gegevens
KW - vaccins/administratie
U2 - 10.1016/j.vaccine.2017.04.014
DO - 10.1016/j.vaccine.2017.04.014
M3 - Article
C2 - 28412075
SN - 0264-410X
VL - 35
SP - 2823
EP - 2830
JO - Vaccine
JF - Vaccine
IS - 21
ER -